Literature DB >> 14621450

Chronic infection and coronary artery disease.

Joseph B Muhlestein1, Jeffrey L Anderson.   

Abstract

On a variety of fronts, chronic infection has been found to be significantly associated with the development of atherosclerosis and the clinical complications of unstable angina, myocardial infarction, and stroke. For the most part, these relationships are still just associations. Failure to confirm initial reports of serologic associations also has been common. Specific causative relationships on par with that determined between H pylori and peptic ulcer disease have not yet been established. Potential mechanisms whereby chronic infections may play a role in atherogenesis are myriad. In the case of C pneumoniae, the effect may result from direct vessel wall colonization that may damage the vessel either directly or indirectly by initiating immunologic responses. In other cases the effect may simply be that of enhancing the pre-existing chronic inflammatory response of the body to standard risk factors such as hyperlipidemia. Even though the infectious agent may not directly infect the vessel wall, it may perform its critical role from afar. Chronic infection might also influence pre-existing plaque by enhancing T-cell activation or other inflammatory responses that may participate in the destabilization of the intimal cap. Hence chronic infection may play a role either in the initiation, progression, or the destabilization of atherosclerotic plaques. The infectious agents with the most evidence to support an etiologic role in atherosclerosis include C pneumoniae and cytomegalovirus. Evidence is mounting for a variety of other potential agents including other herpes viruses, influenza, other specific bacteria (such as M pneumoniae), and chronic infections with common bacterial agents (periodontal disease, chronic bronchitis, and chronic urinary tract infection, among others) [191]. Future studies are expected to elucidate further the pathophysiologic relationship between chronic infection and atherosclerosis and to evaluate further the potential of a variety of treatment approaches, including antibiotics.

Entities:  

Mesh:

Year:  2003        PMID: 14621450     DOI: 10.1016/s0733-8651(03)00054-7

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  14 in total

Review 1.  Coronary artery disease in Bangladesh: a review.

Authors:  A K M Monwarul Islam; A A S Majumder
Journal:  Indian Heart J       Date:  2013-07-10

2.  1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells.

Authors:  O Equils; Y Naiki; A M Shapiro; K Michelsen; D Lu; J Adams; S Jordan
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Immunopathology of desialylation: human plasma lipoprotein(a) and circulating anti-carbohydrate antibodies form immune complexes that recognize host cells.

Authors:  P S Sabarinath; P S Appukuttan
Journal:  Mol Cell Biochem       Date:  2015-01-30       Impact factor: 3.396

Review 4.  [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?].

Authors:  R Fischer-Betz; S Beer; M Schneider
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

5.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

Authors:  Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

6.  Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits.

Authors:  Maria K Schwartz; John C Lieske; Larry W Hunter; Virginia M Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 7.  Contribution of biologically derived nanoparticles to disease.

Authors:  Maria K Schwartz; John C Lieske; Virginia M Miller
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

8.  Persistent pathogens linking socioeconomic position and cardiovascular disease in the US.

Authors:  Amanda M Simanek; Jennifer Beam Dowd; Allison E Aiello
Journal:  Int J Epidemiol       Date:  2008-12-24       Impact factor: 7.196

9.  Economics of health and mortality special feature: race, infection, and arteriosclerosis in the past.

Authors:  Dora L Costa; Lorens A Helmchen; Sven Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

10.  Hydrodynamic regulation of monocyte inflammatory response to an intracellular pathogen.

Authors:  Shankar J Evani; Ashlesh K Murthy; Naresh Mareedu; Robbie K Montgomery; Bernard P Arulanandam; Anand K Ramasubramanian
Journal:  PLoS One       Date:  2011-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.